1. Academic Validation
  2. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket

Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket

  • Bioorg Med Chem. 2021 Jan 1:29:115885. doi: 10.1016/j.bmc.2020.115885.
Matúš Hlaváč 1 Lucia Kováčiková 2 Marta Šoltésová Prnová 2 Gabriela Addová 3 Gilles Hanquet 4 Milan Štefek 2 Andrej Boháč 5
Affiliations

Affiliations

  • 1 Department of Organic Chemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15 Bratislava, Slovakia. Electronic address: matus.hlavac@etu.unistra.fr.
  • 2 Institute of Experimental Pharmacology and Toxicology, CEM, SAS, Dúbravská cesta 9, 841 04 Bratislava, Slovakia.
  • 3 Department of Organic Chemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15 Bratislava, Slovakia.
  • 4 Université de Strasbourg, Université de Haute-Alsace, CNRS, UMR 7042-LIMA, ECPM, 25 rue Becquerel, 67087 Strasbourg, France.
  • 5 Department of Organic Chemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15 Bratislava, Slovakia; Biomagi, Ltd., Mamateyova 26, 851 04 Bratislava, Slovakia.
Abstract

Recently we have developed novel oxotriazinoindole inhibitors (OTIs) of Aldose Reductase (ALR2), characterized by high efficacy and selectivity. Herein we describe novel OTI derivatives design of which is based on implementation of additional intermolecular interactions within an unoccupied pocket of the ALR2 enzyme. Four novel derivatives, OTI-(7-10), of the previously developed N-benzyl(oxotriazinoindole) inhibitor OTI-6 were synthetized and screened. All of them revealed 2 to 6 times higher ALR2 inhibitory efficacy when compared to their non-substituted lead compound OTI-6. Moreover, the most efficient ALR2 inhibitor OTI-7 (IC50 = 76 nM) possesses remarkably high inhibition selectivity (SF ≥ 1300) in relation to structurally related aldehyde reductase (ALR1). Derivatives OTI-(8-10) bearing the substituents -CONH2, -COOH and -CH2OH, possess 2-3 times lower inhibitory efficacy compared to OTI-7, but better than the reference inhibitor OTI-6. Desolvation penalty is suggested as a possible factor responsible for the drop in ALR2 inhibitory efficacy observed for derivatives OTI-(8-10) in comparison to OTI-7.

Keywords

Aldose reductase (ALR2); Desolvation penalty; Interactive pocket; N-benzyl(oxotriazinoindole) ALR2 inhibitors.

Figures
Products